Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 71 of 71 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/22/15
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 01/03/22
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 07/10/18
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 06/30/06
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 01/31/10
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 08/20/15
End: 10/07/21
Due: 10/07/22
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 04/30/26
Due: 04/30/27
Phase: N/A
Priority: Normal
Start: 06/30/07
End: 02/28/14
Due: 02/28/15
Phase: N/A
Priority: Normal
Start: 03/01/21
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 02/08/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 10/31/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/20
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 03/02/22
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 07/12/19
End: 12/22/22
Due: 12/22/23
Phase: N/A
Priority: Normal
Start: 03/18/22
End: 12/31/25
Due: 12/31/26
A Study of Anti-Lewis Y Chimeric Antigen Receptor-T Cells (LeY-CAR-T) in Patients With Solid Tumours
Phase: N/A
Priority: Normal
Start: 11/24/16
End: 04/01/22
Due: 04/01/23
Phase: N/A
Priority: Normal
Start: 09/25/19
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/08/21
End: 09/08/24
Due: 09/08/25
Phase: N/A
Priority: Normal
Start: 09/07/23
End: 06/01/29
Due: 06/01/30
Phase: N/A
Priority: Normal
Start: 12/14/23
End: 05/31/26
Due: 05/31/27